These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36948776)
1. Male Reproduction and Aging. Figueiredo MG; Gagliano-Jucá T; Basaria S Endocrinol Metab Clin North Am; 2023 Jun; 52(2):211-228. PubMed ID: 36948776 [TBL] [Abstract][Full Text] [Related]
2. Reflections on the T Trials. Swerdloff R; Wang C Andrology; 2020 Nov; 8(6):1512-1518. PubMed ID: 32902162 [TBL] [Abstract][Full Text] [Related]
3. Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism. Galbiati FF; Goldman AL; Gattu A; Guzelce EC; Bhasin S Urol Clin North Am; 2022 Nov; 49(4):593-602. PubMed ID: 36309416 [TBL] [Abstract][Full Text] [Related]
4. Androgen deficiency in aging and metabolically challenged men. Shelton JB; Rajfer J Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346 [TBL] [Abstract][Full Text] [Related]
5. Hypotestosteronaemia in the aging male: should we treat it? Christe N; Meier CA Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486 [TBL] [Abstract][Full Text] [Related]
6. Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone. Rodrigues Dos Santos M; Bhasin S Annu Rev Med; 2021 Jan; 72():75-91. PubMed ID: 33217248 [TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798 [TBL] [Abstract][Full Text] [Related]
8. Testosterone treatment in the aging male: myth or reality? Nigro N; Christ-Crain M Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839 [TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of testosterone therapy in older men. Cardona Attard C; Fava S Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of the "aging male"]. Diemer T; Hauck EW; Rohde V; Weidner W Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757 [TBL] [Abstract][Full Text] [Related]
11. EMAS position statement: Testosterone replacement therapy in the aging male. Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257 [TBL] [Abstract][Full Text] [Related]
12. Investigating the basis of sexual dysfunction during late-onset hypogonadism. Tharakan T; Miah S; Jayasena C; Minhas S F1000Res; 2019; 8():. PubMed ID: 30984376 [TBL] [Abstract][Full Text] [Related]
13. Testosterone administration in older men. Matsumoto AM Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401 [TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. Kaplan AL; Trinh QD; Sun M; Carter SC; Nguyen PL; Shih YT; Marks LS; Hu JC J Sex Med; 2014 Apr; 11(4):1063-1070. PubMed ID: 24443943 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913 [TBL] [Abstract][Full Text] [Related]
16. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Lunenfeld B; Saad F; Hoesl CE Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160 [TBL] [Abstract][Full Text] [Related]
17. Testosterone supplementation therapy for older men: potential benefits and risks. Gruenewald DA; Matsumoto AM J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854 [TBL] [Abstract][Full Text] [Related]